Comparison of LTA in Patients with Bleeding Disorder of Unknown Cause and Healthy Blood Donors – Now on RPTH Journal
RPTH Journal shared a post on LinkedIn:
“A new study reassesses guideline-recommended agonist concentrations for light transmission aggregometry (LTA). By comparing individuals with bleeding disorder of unknown cause to healthy donors, the work from Lena-Theresa Fanenbruck highlights important considerations for interpreting LTA results in clinical practice.
Read the full article in RPTH for the full analysis and implications for testing standards.”
Ttile: Comparison of light transmission aggregometry in patients with bleeding disorder of unknown cause and healthy blood donors
Authors: Lena-Theresa Fanenbruck, Michael Metze, Maria Weise, Martin Federbusch, Roland Siegemund, Martin Reinhard Henschler, Annelie Siegemund, Sirak Petros, Christian Pfrepper
Get the latest insights on Hemostasis Today.
-
Aug 21, 2026, 12:08Amy Allen Whitfield: Helping to Proceed Bleeding Disorders Care
-
Aug 21, 2026, 11:53Jan Terje Andersen: Harnessing Placental Biology for Therapeutic Engineering
-
Aug 21, 2026, 11:02Severe ITP, Critical Bleeding, and the Challenge of Platelet Testing – RPTH Journal
-
Aug 21, 2026, 10:46Arwa Z. Al-Riyami: Looking Ahead to ISBT Muscat 2029
-
Aug 21, 2026, 10:42Janine Mothershed: What Is Romiplostim and How Does It Work in Immune Thrombocytopenia?
-
Aug 21, 2026, 10:33Omar Alkharabsheh: Excited to Build the Future of Hematologic Malignancy Care in Central Florida
-
Aug 21, 2026, 10:23Salvador Payán Pernía: Tailoring Therapy in Sickle Cell Disease – Mitapivat and the Path Toward Personalized Combination Care
-
Aug 21, 2026, 10:10Pete Stibbs: The Evolving Landscape of VTE Management
-
Aug 21, 2026, 09:58Nishant K Mishra։ When Epilepsy Meets Anticoagulation